Literature DB >> 207278

Metabolism of 5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5'-triphosphates in human blood and L5178Y cells.

T P Zimmerman, R D Deeprose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 207278     DOI： 10.1016/0006-2952(78)90508-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  29 in total

1.  Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.

Authors:  Julian M W Quinn; Shanna Tam; Natalie A Sims; Hasnawati Saleh; Narelle E McGregor; Ingrid J Poulton; John W Scott; Matthew T Gillespie; Bruce E Kemp; B J W van Denderen
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

Review 2.  Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?

Authors:  Katherine L B Borden; Biljana Culjkovic-Kraljacic
Journal:  Leuk Lymphoma       Date:  2010-10

3.  Ribavirin can be mutagenic for arenaviruses.

Authors:  Héctor Moreno; Isabel Gallego; Noemí Sevilla; Juan Carlos de la Torre; Esteban Domingo; Verónica Martín
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

Review 4.  Antiviral therapy with small particle aerosols.

Authors:  V Knight; B Gilbert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

Review 5.  Biochemistry and clinical applications of ribavirin.

Authors:  B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

Review 6.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

7.  Effect of adenosine and AICAR on ATP content and regional contractile function in reperfused canine myocardium.

Authors:  H M Hoffmeister; M Mauser; W Schaper
Journal:  Basic Res Cardiol       Date:  1985 Jul-Aug       Impact factor: 17.165

8.  Disposition and metabolic profiles of [14C]viramidine and [14C]ribavirin in rat and monkey red blood cells and liver.

Authors:  Chin-Chung Lin; David Lourenco; Guifen Xu; Li-Tain Yeh
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.

Authors:  J J Kirsi; J A North; P A McKernan; B K Murray; P G Canonico; J W Huggins; P C Srivastava; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

Review 10.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.